|
1.
|
LM DeAngelisBrain tumorsN Engl J
Med34411423200110.1056/NEJM200101113440207
|
|
2.
|
JA SchwartzbaumJL FisherKD AldapeM
WrenschEpidemiology and molecular pathology of gliomaNat Clin Pract
Neurol2494503200610.1038/ncpneuro028916932614
|
|
3.
|
Y LiuS SheteCJ EtzelM ScheurerG AlexiouG
ArmstrongPolymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes
involved in the double-strand break repair pathway predict
glioblastoma survivalJ Clin
Oncol2824672474201010.1200/JCO.2009.26.621320368557
|
|
4.
|
JN ScottNB RewcastlePM BrasherD FultonJA
MacKinnonM HamiltonWhich glioblastoma multiforme patient will
become a long-term survivor? A population-based studyAnn
Neurol46183188199910.1002/1531-8249(199908)46:2%3C183::AID-ANA7%3E3.0.CO;2-710443883
|
|
5.
|
R StuppWP MasonMJ van den BentM WellerB
FisherMJ TaphoornRadiotherapy plus concomitant and adjuvant
temozolomide for glioblastomaN Engl J
Med352987996200510.1056/NEJMoa04333015758009
|
|
6.
|
E GalanisJC BucknerRP DinapoliBW
ScheithauerRB JenkinsCH WangClinical outcome of gliosarcoma
compared with glioblastoma multiforme: North Central Cancer
Treatment Group resultsJ
Neurosurg89425430199810.3171/jns.1998.89.3.0425
|
|
7.
|
J LutterbachR GuttenbergerA
PagenstecherGliosarcoma: a clinical studyRadiother
Oncol615764200110.1016/S0167-8140(01)00415-711578729
|
|
8.
|
C AdamsonOO KanuAI MehtaC DiN LinAK
MattoxGlioblastoma multiforme: a review of where we have been and
where we are goingExpert Opin Investig
Drugs1810611083200910.1517/1354378090305276419555299
|
|
9.
|
K ChaichanaS ParkerA OliviA
Quinones-HinojosaA proposed classification system that projects
outcomes based on preoperative variables for adult patients with
glioblastoma multiformeJ
Neurosurg1129971004201010.3171/2009.9.JNS09805
|
|
10.
|
N El HindyHS BachmannN LambertzM AdamzikH
NückelK WormAssociation of the CC genotype of the regulatory BCL2
promoter polymorphism (−938C>A) with better 2-year survival in
patients with glioblastoma multiformeJ Neurosurg114163116392011
|
|
11.
|
X ChengY LiZ XuD LiJ WangA meta-analysis
of (99m) Tc-MIBI SPECT for detection of recurrent glioma after
radiation therapyJ Clin
Neurosci18307312201110.1016/j.jocn.2010.07.11321251837
|
|
12.
|
K KallénIM BurtscherS HoltåsE RydingI
Rosén201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy
monitoring of high-grade malignant astrocytomasJ
Neurooncol46173185200010894370
|
|
13.
|
F Prigent-Le JeuneF DuboisS PerezS BlondM
SteinlingTechnetium-99m sestamibi brain SPECT in the follow-up of
glioma for evaluation of response to chemotherapy: first resultsEur
J Nucl Med Mol Imaging31714719200414985865
|
|
14.
|
RB SchwartzBL HolmanJF PolakBM GaradaMS
SchwartzR FolkerthDual-isotope single-photon emission computerized
tomography scanning in patients with glioblastoma multiforme:
association with patient survival and histopatho-logical
characteristics of tumor after high-dose radiotherapyJ
Neurosurg896068199810.3171/jns.1998.89.1.0060
|
|
15.
|
I AkZ GulbasF AltinelE VardareliTc-99m
MIBI uptake and its relation to the proliferative potential of
brain tumorsClin Nucl
Med282933200310.1097/00003072-200301000-0000712493957
|
|
16.
|
GA AlexiouS TsiourisAP KyritsisG
FotakopoulosA GoussiaS VoulgarisThe value of 99mTc-tetrofosmin
brain SPECT in predicting survival in patients with glioblastoma
multiformeJ Nucl
Med5119231926201010.2967/jnumed.110.08092921078797
|
|
17.
|
P BeauchesneR PedeuxM BoniolC
Soler99mTc-sestamibi brain SPECT after chemoradiotherapy is
prognostic of survival in patients with high-grade gliomaJ Nucl
Med45409413200415001680
|
|
18.
|
P BeauchesneC SolerCorrelation of
99mTc-MIBI brain spect (functional index ratios) and survival after
treatment failure in malignant glioma patientsAnticancer
Res22308130852002
|
|
19.
|
S NagamachiS JinnouchiK NabeshimaR NishiiL
Flores IIT KodamaThe correlation between 99mTc-MIBI uptake and
MIB-1 as a nuclear proliferation marker in glioma - a comparative
study with
201TlNeuroradiology4310231030200110.1007/s00234010062911792039
|
|
20.
|
VP DeltuvaN JurkieneI KulakieneA
BuneviciusA MatukeviciusA TamasauskasIntroduction of novel
semi-quantitative evaluation of 99mTc-MIBI SPECT before and after
treatment for gliomaMedicina (Kaunas)4811521201222481370
|
|
21.
|
L FilippiR SantoniC ManniR DanieliR
FlorisO SchillaciImaging primary bain tumors by single-photon
emission computerized tomography (SPECT) with technetium-99m
sestabimi (MIBI) and tetrofosminCurrent Medical Imaging
Reviews16166200510.2174/1573405052953047
|
|
22.
|
RE HenkinD BovaGL DillehayJR HalamaSM
KareshRH WagnerNuclear Medicine2nd editionMosby
ElsevierPhiladelphia1371532006
|
|
23.
|
T SembaY SugawaraT OchiT FujiiT MochizukiT
OhnishiThallium-201 SPECT in prognostic assessment of malignant
gliomas treated with postoperative radiotherapyAnn Nucl
Med20287294200610.1007/BF0298464516856572
|
|
24.
|
MV PadmaS SaidM JacobsDR HwangK DuniganM
SatterPrediction of pathology and survival by FDG PET in gliomasJ
Neurooncol64227237200310.1023/A:102566582000114558598
|
|
25.
|
NJ PatronasG Di ChiroC KuftaD BairamianPL
KornblithR SimonPrediction of survival in glioma patients by means
of positron emission tomographyJ
Neurosurg62816822198510.3171/jns.1985.62.6.08162987440
|
|
26.
|
WS ChenKE LukerJL DahlheimerCM PicaGD
LukerD Piwnica-WormsEffects of MDR1 and MDR3 P-glycoproteins, MRP1,
and BCRP/MXR/ABCP on the transport of (99m) Tc-tetrofosminBiochem
Pharmacol60413426200010.1016/S0006-2952(00)00341-510856437
|
|
27.
|
LI Delmon-MoingeonD Piwnica-WormsAD Van
den AbbeeleBL HolmanA DavisonAG JonesUptake of the cation
hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human
carcinoma cell lines in vitroCancer Res50219820219902317808
|
|
28.
|
U PichlmeierA BinkG SchackertW StummerALA
Glioma Study GroupResection and survival in glioblastoma
multiforme: an RTOG recursive partitioning analysis of ALA study
patientsNeuro
Oncol1010251034200810.1215/15228517-2008-05218667747
|
|
29.
|
N SanaiMY PolleyMW McDermottAT ParsaMS
BergerAn extent of resection threshold for newly diagnosed
glioblastomasJ
Neurosurg11538201110.3171/2011.2.JNS1099821417701
|
